Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Nicole Bodmer et al.|Blood|2023Cited by 1
Drug response profiling guides precision therapy in relapsed and refractory childhood acute lymphoblastic leukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Andrej Lissat et al.|medRxiv|2026Cited by 0